Precision Computional Oncology
that de-risks your entire cohort before the trial even begins.
ACTIVE GATE
CrisPRO has NCI-approved access to the PLCO ovarian screening trial — 78,000 women, 72 confirmed cancers, six years of serial CA-125 under CDAS Project PLCO-2010.
01/06